These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28285783)

  • 21. Nodular morphea (NM): report of a case of concurrent NM and morphea profunda associated with limited type systemic sclerosis, and overview and definition for NM.
    Ohata C; Yasunaga M; Tsuruta D; Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Hashimoto T
    Eur J Dermatol; 2013; 23(1):87-93. PubMed ID: 23400240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological study of 81 cases of localized and systemic scleroderma.
    Succaria F; Kurban M; Kibbi AG; Abbas O
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e191-6. PubMed ID: 22620486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep morphea.
    Bielsa I; Ariza A
    Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of morphea (localized scleroderma).
    Peterson LS; Nelson AM; Su WP
    Mayo Clin Proc; 1995 Nov; 70(11):1068-76. PubMed ID: 7475336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of morphea and systemic sclerosis.
    Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
    Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
    Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
    J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris.
    Saleh Z; Arayssi T; Saleh Z; Ghosn S
    J Cutan Pathol; 2009 Oct; 36(10):1105-8. PubMed ID: 19602063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choroidal sclerosis in localized scleroderma (morphea en plaque).
    Milenkovic S; Petrovic L; Risimic D; Kosanovic-Jakovic N; Jaksic V; Djakovic Z; Stojkovic M; Risovic D; Ivankovic Lj; Ivancevic-Milenkovic M
    Ophthalmic Res; 2008; 40(2):101-4. PubMed ID: 18223304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elastic fiber pattern in scleroderma/morphea.
    Walters R; Pulitzer M; Kamino H
    J Cutan Pathol; 2009 Sep; 36(9):952-7. PubMed ID: 19674200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized morphea: a rare adverse effect of valproic acid.
    Ferzli GT; El-Tal Ael-K; Kibbi AG; Mikati MA
    Pediatr Neurol; 2003 Sep; 29(3):253-5. PubMed ID: 14629913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodular morphea.
    Kauer F; Simon JC; Sticherling M
    Dermatology; 2009; 218(1):63-6. PubMed ID: 19005241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathology of morphea: Sensitivity of various named signs, a retrospective study.
    Jindal R; Shirazi N; Chauhan P
    Indian J Pathol Microbiol; 2020; 63(4):600-603. PubMed ID: 33154313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "Line Sign" Is a Rapid and Efficient Diagnostic "Test" for Morphea: Clinicopathological Study of 73 Cases.
    Yang S; Draznin M; Fung MA
    Am J Dermatopathol; 2018 Dec; 40(12):873-878. PubMed ID: 30475273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity assessment in morphea using color Doppler ultrasound.
    Wortsman X; Wortsman J; Sazunic I; Carreño L
    J Am Acad Dermatol; 2011 Nov; 65(5):942-8. PubMed ID: 21550692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia).
    Adeeb F; Anjum S; Hodnett P; Kashif A; Brady M; Morrissey S; Devlin J; Fraser AD
    Semin Arthritis Rheum; 2017 Jun; 46(6):775-781. PubMed ID: 27773434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea.
    Parra-Cares J; Wortsman X; Alfaro-Sepúlveda D; Mellado-Francisco G; Ramírez-Cornejo C; Vera-Kellet C
    J Cutan Med Surg; 2023; 27(5):454-460. PubMed ID: 37533149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.